Skip to main content
Premium Trial:

Request an Annual Quote

Applied DNA Sciences to Acquire IP from Biowell Technologies

NEW YORK, Feb. 8 (GenomeWeb News) - Applied DNA Sciences said today that it will acquire all rights, title, and interest in the intellectual property of Biowell Technologies, including DNA technology used in Biowell's global security and anti-counterfeiting applications.

 

Under the terms of the agreement, Taiwan-based Biowell will transfer ownership of its IP to a subsidiary, which a wholly owned subsidiary of Applied DNA will subsequently acquire, the companies said.

 

In exchange, Biowell shareholders will receive shares of Applied DNA Sciences' common stock.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.